biospecimen_aliquot__bcr_aliquot_barcode	tcga-a2-a04v-01a-21w-a050-09
biospecimen_aliquot__bcr_aliquot_uuid	89501861-2778-4b88-9a44-939fed99850d
biospecimen_aliquot__bcr_patient_uuid	64f67506-f2df-4f0a-b7be-29b4949e986a
biospecimen_aliquot__bcr_sample_barcode	tcga-a2-a04v-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0100470727
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.50
biospecimen_aliquot__date_of_shipment	2010-08-09
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	12
biospecimen_aliquot__plate_id	a050
biospecimen_aliquot__plate_row	a
biospecimen_aliquot__quantity	40.00
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	80.00
biospecimen_analyte__analyte_type	repli-g (qiagen) dna
biospecimen_analyte__analyte_type_id	w
biospecimen_analyte__bcr_analyte_barcode	tcga-a2-a04v-01a-21w
biospecimen_analyte__bcr_analyte_uuid	ae6e5574-0d73-41e5-83e4-bc4a9bd579b3
biospecimen_analyte__bcr_patient_uuid	64f67506-f2df-4f0a-b7be-29b4949e986a
biospecimen_analyte__bcr_sample_barcode	tcga-a2-a04v-01a
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-a2-a04v
biospecimen_diagnostic_slides__bcr_patient_uuid	64f67506-f2df-4f0a-b7be-29b4949e986a
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-a2-a04v-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	eb430ddb-8fe9-4302-8829-53dbad09e79f
biospecimen_normal_control__bcr_patient_barcode	tcga-a2-a04v
biospecimen_normal_control__bcr_patient_uuid	64f67506-f2df-4f0a-b7be-29b4949e986a
biospecimen_normal_control__ncedna_dna_conc	0.3133
biospecimen_normal_control__ncedna_dna_qm	spec (nano drop)
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	63.8
biospecimen_portion__bcr_patient_uuid	64f67506-f2df-4f0a-b7be-29b4949e986a
biospecimen_portion__bcr_portion_barcode	tcga-a2-a04v-01a-21
biospecimen_portion__bcr_portion_uuid	f10b57a7-c211-4315-a0e6-03a300bd6e33
biospecimen_portion__bcr_sample_barcode	tcga-a2-a04v-01a
biospecimen_portion__date_of_creation	2010-06-09
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	21
biospecimen_portion__portion_sequence	2
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-a2-a04v-01a-21w
biospecimen_protocol__bcr_patient_uuid	64f67506-f2df-4f0a-b7be-29b4949e986a
biospecimen_protocol__bcr_sample_barcode	tcga-a2-a04v-01a
biospecimen_protocol__experimental_protocol_type	repli-g
biospecimen_sample__bcr_patient_uuid	64f67506-f2df-4f0a-b7be-29b4949e986a
biospecimen_sample__bcr_sample_barcode	tcga-a2-a04v-01a
biospecimen_sample__bcr_sample_uuid	5dfab1d0-fed6-47b2-a47d-402e088361ad
biospecimen_sample__days_to_collection	1812
biospecimen_sample__initial_weight	200
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-a2-a04v.7d84a145-19af-48d0-a5d9-f5724068cb26.pdf
biospecimen_sample__pathology_report_uuid	7d84a145-19af-48d0-a5d9-f5724068cb26
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	64f67506-f2df-4f0a-b7be-29b4949e986a
biospecimen_shipment_portion__bcr_sample_barcode	tcga-a2-a04v-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	676bd916-c1a1-4b1f-b406-0c3bae66640e
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13a
biospecimen_shipment_portion__portion_number	11
biospecimen_shipment_portion__portion_sequence	1
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-a2-a04v-01a-11-a13a-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	64f67506-f2df-4f0a-b7be-29b4949e986a
biospecimen_slide__bcr_sample_barcode	tcga-a2-a04v-01a
biospecimen_slide__bcr_slide_barcode	tcga-a2-a04v-01a-02-ms2
biospecimen_slide__bcr_slide_uuid	9f2d5cc6-ef65-4465-bec7-4d7151ad39f1
biospecimen_slide__image_file_name	tcga-a2-a04v-01a-02-ms2.9f2d5cc6-ef65-4465-bec7-4d7151ad39f1.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	10
biospecimen_slide__percent_tumor_cells	90
biospecimen_slide__percent_tumor_nuclei	90
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-a2-a04v
biospecimen_tumor_sample__bcr_patient_uuid	64f67506-f2df-4f0a-b7be-29b4949e986a
clinical_drug__bcr_drug_barcode	tcga-a2-a04v-d2673
clinical_drug__bcr_drug_uuid	41160c56-81c5-42b7-83b8-cc0018073cac
clinical_drug__bcr_patient_barcode	tcga-a2-a04v
clinical_drug__bcr_patient_uuid	64f67506-f2df-4f0a-b7be-29b4949e986a
clinical_drug__form_completion_date	2010-8-11
clinical_drug__pharmaceutical_therapy_drug_name	exemestane
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_dose_units	mg
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	1452
clinical_drug__prescribed_dose	25
clinical_drug__regimen_number	4
clinical_drug__route_of_administration	po
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-a2-a04v-f10273
clinical_follow_up__bcr_followup_uuid	8a12f731-0d21-451d-aed9-2677f2356de2
clinical_follow_up__bcr_patient_barcode	tcga-a2-a04v
clinical_follow_up__bcr_patient_uuid	64f67506-f2df-4f0a-b7be-29b4949e986a
clinical_follow_up__death_days_to	1920
clinical_follow_up__form_completion_date	2011-3-18
clinical_follow_up__new_tumor_event_dx_days_to	1470
clinical_follow_up__new_tumor_event_pharmaceutical_tx	yes
clinical_follow_up__new_tumor_event_radiation_tx	no
clinical_follow_up__new_tumor_event_surgery	no
clinical_follow_up__new_tumor_event_surgery_met	no
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	with tumor
clinical_follow_up__vital_status	dead
clinical_nte__bcr_patient_barcode	tcga-a2-a04v
clinical_nte__bcr_patient_uuid	64f67506-f2df-4f0a-b7be-29b4949e986a
clinical_omf__bcr_omf_barcode	tcga-a2-a04v-o12162
clinical_omf__bcr_omf_uuid	e16fccbc-062f-4054-9f8d-eb0e1943ee6a
clinical_omf__bcr_patient_barcode	tcga-a2-a04v
clinical_omf__bcr_patient_uuid	64f67506-f2df-4f0a-b7be-29b4949e986a
clinical_omf__days_to_surgical_resection	15
clinical_omf__drug_name	[not available]|adriamycin|tamoxifen|letrozole|exemestane|[not available]
clinical_omf__drug_tx_indicator	no
clinical_omf__form_completion_date	2011-5-25
clinical_omf__malignancy_type	synchronous malignancy
clinical_omf__other_malignancy_anatomic_site	breast
clinical_omf__other_malignancy_histological_type	other, specify
clinical_omf__other_malignancy_histological_type_text	infiltrating ductal carcinoma
clinical_omf__other_malignancy_laterality	left
clinical_omf__pathologic_M	m0
clinical_omf__pathologic_N	n0
clinical_omf__pathologic_T	t2
clinical_omf__pathologic_stage	stage iia
clinical_omf__radiation_tx_indicator	no
clinical_omf__system_version	7th
clinical_patient__age_at_diagnosis	39
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0 (i-)
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	right lower outer quadrant|right
clinical_patient__axillary_staging_method	sentinel node biopsy alone
clinical_patient__bcr_patient_barcode	tcga-a2-a04v
clinical_patient__bcr_patient_uuid	64f67506-f2df-4f0a-b7be-29b4949e986a
clinical_patient__birth_days_to	-14250
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__death_days_to	1920
clinical_patient__er_positivity_scale_other	strong
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	90-99%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2010-8-10
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	1.1
clinical_patient__her2_fish_status	negative
clinical_patient__her2_ihc_score	2+
clinical_patient__her2_status_by_ihc	equivocal
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2005
clinical_patient__lymph_nodes_examined_count	2
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__lymph_nodes_examined_ihc_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	yes
clinical_patient__patient_id	a04v
clinical_patient__pr_positivity_scale_other	moderate
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	10-19%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	simple mastectomy
clinical_patient__tissue_source_site	a2
clinical_patient__tumor_status	with tumor
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	dead
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A04V-01A-21W-A050-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A04V-01A-21W-A050-09.bed.meta
manually_curated__id	tcga-a2-a04v-01a-21w-a050-09
manually_curated__md5sum	514c693ea78341075ec0d6fe9081ed41
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	89501861-2778-4b88-9a44-939fed99850d
manually_curated__tumor_tag	brca
